4zso
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Crystal structure of a complex between B7-H6, a tumor cell ligand for natural cytotoxicity receptor NKp30, and an inhibitory antibody== | ==Crystal structure of a complex between B7-H6, a tumor cell ligand for natural cytotoxicity receptor NKp30, and an inhibitory antibody== | ||
| - | <StructureSection load='4zso' size='340' side='right' caption='[[4zso]], [[Resolution|resolution]] 2.50Å' scene=''> | + | <StructureSection load='4zso' size='340' side='right'caption='[[4zso]], [[Resolution|resolution]] 2.50Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4zso]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZSO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZSO FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4zso]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4ZSO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ZSO FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACY:ACETIC+ACID'>ACY</scene>, <scene name='pdbligand=FUC:ALPHA-L-FUCOSE'>FUC</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | ||
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4zso FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zso OCA], [http://pdbe.org/4zso PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4zso RCSB], [http://www.ebi.ac.uk/pdbsum/4zso PDBsum]</span></td></tr> | + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">NCR3LG1, B7H6 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> |
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4zso FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4zso OCA], [http://pdbe.org/4zso PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4zso RCSB], [http://www.ebi.ac.uk/pdbsum/4zso PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4zso ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Function == | == Function == | ||
[[http://www.uniprot.org/uniprot/NR3L1_HUMAN NR3L1_HUMAN]] Triggers NCR3-dependent natural killer cell activation.<ref>PMID:19528259</ref> | [[http://www.uniprot.org/uniprot/NR3L1_HUMAN NR3L1_HUMAN]] Triggers NCR3-dependent natural killer cell activation.<ref>PMID:19528259</ref> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Antibody 3D structures|Antibody 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Human]] | ||
| + | [[Category: Large Structures]] | ||
[[Category: Li, Y]] | [[Category: Li, Y]] | ||
[[Category: Mariuzza, R A]] | [[Category: Mariuzza, R A]] | ||
Revision as of 08:45, 26 June 2019
Crystal structure of a complex between B7-H6, a tumor cell ligand for natural cytotoxicity receptor NKp30, and an inhibitory antibody
| |||||||||||
